Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 2001, p. 811-813, Vol. 21, No. 3
Department of Molecular and Human
Genetics1 and Department of
Pediatrics,3 Baylor College of Medicine,
Houston, Texas 77030; Department of Molecular Genetics and
Biochemistry, University of Pittsburgh, Pittsburgh, Pennsylvania
152612; and Grace Cancer Drug Center,
Roswell Park Cancer Institute, Buffalo, New York
142634
Received 6 September 2000/Accepted 8 November 2000
Mammals express two isoforms of arginase, designated types I and
II. Arginase I is a component of the urea cycle, and inherited defects
in arginase I have deleterious consequences in humans. In contrast, the
physiologic role of arginase II has not been defined, and no
deficiencies in arginase II have been identified in humans. Mice with a
disruption in the arginase II gene were created to investigate the role
of this enzyme. Homozygous arginase II-deficient mice were viable and
apparently indistinguishable from wild-type mice, except for an
elevated plasma arginine level which indicates that arginase II plays
an important role in arginine homeostasis.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.3.811-813.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Generation of a Mouse Model for Arginase II
Deficiency by Targeted Disruption of the Arginase II Gene
*
Corresponding author. Mailing address: Department of
Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030. Phone: (713) 798-5484. Fax: (713) 798-8937. E-mail:
wobrien{at}bcm.tmc.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|